Cat.#: ACPP-1549
| Despition | VEGF C Human Recombinant |
| SIZE | 2 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1833 | Human CRMP1 Protein (AC1833) | 5 µg | inquiry |
| ACPP-1384 | Human RPL5 Protein (AC1384) | 2 µg | inquiry |
| ACPP-1525 | Human PCDHGC4 Protein (AC1525) | 5 µg | inquiry |
| ACPP-1146 | Recombinant Human Artemin Protein (Fc Tag) (AC1146) | 50 µg | inquiry |
| ACPP-1049 | Recombinant Human Galectin 3 Protein (6×His Tag) (AC1049) | 50 µg | inquiry |
| ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
| ACPP-1099 | Synthetic Nanodisc Human Adenosine Receptor A2a Protein (AC1099) | 10 µg | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
| ACPP-1317 | Noelin Blocking Peptide (AC1317) | 250 µg | inquiry |
| ACPP-1328 | MRAP2 Blocking Peptide (AC1328) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.